Malic Enzyme inhibitor ME1 is primarily used in research to study metabolic pathways, particularly those involving malic enzyme 1 (ME1). It helps in understanding the role of ME1 in cancer metabolism, as ME1 is often overexpressed in certain cancers, contributing to tumor growth and survival. By inhibiting ME1, researchers can explore its impact on lipid synthesis, NADPH production, and redox balance in cancer cells. This inhibitor is also valuable in investigating metabolic disorders and developing potential therapeutic strategies targeting metabolic dysregulation. Additionally, it aids in elucidating the enzyme's role in cellular energy production and its connection to oxidative stress.